What is Biofil Chemicals & Pharmaceuticals Limited's latest revenue?

Biofil Chemicals & Pharmaceuticals Limited reported revenue of ₹28.4 Cr in its latest annual results, per the filed results.

What is Biofil Chemicals & Pharmaceuticals Limited's latest net profit?

Biofil Chemicals & Pharmaceuticals Limited reported net profit of ₹2.8 Cr in its latest annual results, per the filed results.

What is Biofil Chemicals & Pharmaceuticals Limited's return on equity?

Biofil Chemicals & Pharmaceuticals Limited posted ROE of 2.2% and ROCE of 4.0% for its latest annual results, computed from filed statements.

What is Biofil Chemicals & Pharmaceuticals Limited's operating margin?

Biofil Chemicals & Pharmaceuticals Limited's operating margin was 12.2% in its latest annual results, derived from filed operating expenses.

How much did Biofil Chemicals & Pharmaceuticals Limited's revenue grow year-on-year?

Biofil Chemicals & Pharmaceuticals Limited's revenue changed -15.0% year-on-year in its latest annual results, per the filed results.

BIO

BIOFILCHEM

Name: Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) quarterly results & financial statements
Creator: Upmazing

Biofil Chemicals & Pharmaceuticals Limited

HealthcarePharmaceuticals & Biotechnology

ISIN INE829A01014

—

Day

52W

MCap₹52.08 Cr

weakUpmazing Score

Open chart ↗

BIO

BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Limited

HealthcarePharmaceuticals & Biotechnology

ISIN INE829A01014

—

Day

52W

MCap₹52.08 Cr

weakUpmazing Score

Open chart ↗

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) reported revenue of ₹12.35 Cr and net profit of ₹10.91 L for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.

BIOFILCHEM fundamentals, Fundamental score 30/100

The statements below are read from Biofil Chemicals & Pharmaceuticals Limited’s filed results, 28 filed quarters and 11 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.

Latest: Q1 FY26-27 · filed Aug 12, 2026 · audited

Sales CAGR · 3Y−1.9%FY22 → FY25

Sales CAGR · 4Y+6.1%FY21 → FY25

PAT CAGR · 3Y+70.7%FY22 → FY25

PAT CAGR · 4Y+41.3%FY21 → FY25

Price · 1Y−25.6%EOD

Price CAGR · 3Y−13.7%EOD

Quarterly resultsStandalone

₹ Cr	Dec2018	Jun2019	Sep2019	Dec2019	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026Latest	YoYlatest
Sales	14.3	1.59	11.6	12.8	16.0	3.19	14.2	5.37	13.7	1.63	1.65	12.3	2.62	1.49	13.6	2.43	17.4	5.03	15.2	8.44	2.41	14.2	8.35	6.43	13.5	0.86	7.57	12.4	+92.0%
	14.0	1.57	10.9	12.6	15.1	2.58	13.9	5.04	13.4	1.14	1.50	11.9	2.46	1.27	13.2	2.02	17.1	4.84	15.2	8.14	2.29	13.9	8.24	6.43	13.4	0.76	7.13	12.2	+90.0%
Operating profit	—	—	—	—	0.91	0.61	0.37	0.33	0.37	0.49	0.14	0.38	0.15	0.23	0.41	0.42	0.24	0.19	-0.03	0.31	0.12	0.31	0.11	0.01	0.11	0.09	0.43	0.14	n/m
OPM %	—	—	—	—	5.7%	19.1%	2.6%	6.2%	2.7%	29.8%	8.6%	3.1%	5.9%	15.2%	3.0%	17.2%	1.4%	3.8%	-0.2%	3.6%	5.2%	2.2%	1.3%	0.1%	0.8%	11.1%	5.7%	1.1%	+1.0 pp
Other income	0.02	0.01	0.03	0.09	0.15	0.02	-0.00	0.02	0.03	0.07	0.03	0.02	0.02	0.02	0.03	0.02	0.03	0.03	0.41	0.03	0.02	0.02	0.24	2.83	0.06	0.08	0.11	0.06	-97.8%
Interest	—	—	—	—	0.02	0.01	-0.09	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.02	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	-92.5%
Depreciation	—	—	—	—	0.11	0.11	0.19	0.10	0.10	0.10	0.12	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.08	0.10	0.10	0.10	0.08	0.07	0.07	0.07	0.07	0.07	+3.6%
Profit before tax	0.29	0.04	0.79	0.23	0.93	0.51	0.26	0.24	0.29	0.44	0.04	0.28	0.06	0.13	0.32	0.32	0.15	0.11	0.27	0.23	0.03	0.22	0.25	2.76	0.11	0.11	0.47	0.13	-95.1%
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	27.8%	26.8%	22.7%	166.1%	25.2%	25.2%	25.1%	35.4%	24.7%	19.6%	17.7%	9.5%	25.7%	25.6%	25.8%	21.4%	12.7%	25.2%	25.8%	54.7%	18.6%	+5.9 pp
Net profit	0.29	0.04	0.79	0.23	0.93	0.51	-0.41	0.17	0.21	0.34	-0.03	0.21	0.05	0.10	0.21	0.24	0.12	0.09	0.25	0.17	0.02	0.16	0.20	2.41	0.08	0.08	0.21	0.11	-95.5%
EPS (₹)	—	—	—	—	0.57	0.31	-0.25	0.11	0.13	0.21	-0.01	0.13	0.03	0.06	0.07	0.15	0.08	0.06	0.15	0.10	0.01	0.10	0.12	1.48	0.05	0.05	0.13	0.07	-95.3%

One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters

Revenue & net profit trend

last 20 quarters

RevenueNet profit

Revenue & net profit — Standalone20 quarters

Segment results

Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.

Forensic checksauto-scanned from the filing

Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.

How results moved the priceEOD reaction on the session the market could trade the filing

Avg absolute result-day move ±1.5%· EPS surprise: no estimates source

Q1'27filed Tue 11 Aug 18:08 · first tradeable session Wed 12 Auggap +2.1%close +0.1%

Q4'26filed Sat 30 May 19:08 · first tradeable session Mon 1 Jungap +0.0%close −0.8%

Q3'26filed Fri 13 Feb 18:42 · first tradeable session Mon 16 Febgap −0.3%close −4.3%

Q2'26filed Thu 13 Nov 19:04 · first tradeable session Fri 14 Novgap +0.0%close −0.3%

Q1'26filed Tue 12 Aug 19:33 · first tradeable session Wed 13 Auggap −4.1%close −2.9%

Q4'25filed Fri 30 May 18:36 · first tradeable session Mon 2 Jungap +0.2%close −1.5%

Q3'25filed Tue 11 Feb 17:30 · first tradeable session Wed 12 Febgap +2.0%close +1.4%

Q2'25filed Thu 14 Nov 19:17 · first tradeable session Mon 18 Novgap −2.5%close −3.9%

Q1'25filed Tue 13 Aug 18:33 · first tradeable session Wed 14 Auggap −0.0%close −1.5%

Q4'24filed Thu 30 May 18:48 · first tradeable session Fri 31 Maygap +3.2%close −1.0%

Q3'24filed Tue 6 Feb 20:47 · first tradeable session Wed 7 Febgap +0.0%close +5.0%

Q2'24filed Thu 9 Nov 19:33 · first tradeable session Fri 10 Novgap +0.0%close +0.2%

Q1'24filed Mon 14 Aug 18:12 · first tradeable session Wed 16 Auggap +0.4%close −0.5%

Q4'23filed Tue 30 May 18:54 · first tradeable session Wed 31 Maygap +0.1%close −1.2%

Q3'23filed Tue 14 Feb 17:23 · first tradeable session Wed 15 Febgap +0.4%close +1.8%

Q2'23filed Mon 14 Nov 19:48 · first tradeable session Tue 15 Novgap −1.6%close −2.3%

Q1'23filed Tue 9 Aug 17:57 · first tradeable session Wed 10 Auggap −2.2%close −0.3%

Q4'22filed Mon 30 May 20:21 · first tradeable session Tue 31 Maygap −2.1%close −0.2%

Q3'22filed Mon 14 Feb 17:40 · first tradeable session Tue 15 Febgap −6.7%close −0.7%

Q2'22filed Fri 12 Nov 16:32 · first tradeable session Mon 15 Novgap +1.9%close −0.8%

PeriodQ1 FY26-27BasisStandaloneFiledAug 12, 2026Qualityaudited

Frequently Asked Questions

What is Biofil Chemicals & Pharmaceuticals Limited's latest revenue?: Biofil Chemicals & Pharmaceuticals Limited reported revenue of ₹28.4 Cr in its latest annual results, per the filed results.
What is Biofil Chemicals & Pharmaceuticals Limited's latest net profit?: Biofil Chemicals & Pharmaceuticals Limited reported net profit of ₹2.8 Cr in its latest annual results, per the filed results.
What is Biofil Chemicals & Pharmaceuticals Limited's return on equity?: Biofil Chemicals & Pharmaceuticals Limited posted ROE of 2.2% and ROCE of 4.0% for its latest annual results, computed from filed statements.
What is Biofil Chemicals & Pharmaceuticals Limited's operating margin?: Biofil Chemicals & Pharmaceuticals Limited's operating margin was 12.2% in its latest annual results, derived from filed operating expenses.
How much did Biofil Chemicals & Pharmaceuticals Limited's revenue grow year-on-year?: Biofil Chemicals & Pharmaceuticals Limited's revenue changed -15.0% year-on-year in its latest annual results, per the filed results.